Congenital nephrogenic diabetes insipidus (CNDI) is a rare hereditary disorder. It is associated with mutations in the arginine vasopressin receptor 2 (AVPR2) gene and aquaporin 2 (AQP2) gene, and approximately 270 different mutation sites have been reported for AVPR2. Therefore, new mutations and new manifestations are crucial to complement the clinical deficiencies in the diagnosis of this disease. We report a case of a novel AVPR2 gene mutation locus and a new clinical mani-festation.

We describe the case of a 48-d-old boy who presented with recurrent fever and diarrhea 5 d after birth. Laboratory tests showed electrolyte disturbances and low urine specific gravity, and imaging tests showed no abnormalities. Genetic testing revealed a novel X-linked recessive missense mutation, c.283 (exon 2) C>T (p.P95S). This mutation results in the substitution of a proline residue with a serine residue in the AVPR2 protein sequence. The diagnosis of CNDI was confirmed based on the AVPR2 gene mutation. The treatment strategy for this patient was divided into two stages, including physical cooling supplemented with appropriate amounts of water in the early stage and oral hydrochlorothia-zide (1-2 mg/kg) after a clear diagnosis. After follow-up of one and a half years, the patient gradually improved.

AVPR2 gene mutations in new loci and new clinical symptoms help clinicians understand this disease and shorten the diagnosis cycle.

• Congenital nephrogenic diabetes insipidus
• Arginine vasopressin receptor 2 gene mutation
• New site
• Diarrhea
• Case report

• Adolescent
• Adult
• Child
• Child, Preschool
• Diabetes Insipidus/complications
• Diabetes Insipidus/etiology
• Diabetes Insipidus/genetics
• Diabetes Insipidus/therapy
• Follow-Up Studies
• Humans
• Hydronephrosis/etiology
• Hypothalamo-Hypophyseal System
• Infant
• Kidney Concentrating Ability
• Pituitary Gland, Posterior/metabolism
• Vasopressins/deficiency